Software Development Standard and Software Engineering Practice: A Case Study of Bangladesh

Improving software process to achieve high quality in a software development organization is the key factor to success. Bangladeshi software firms have not experienced much in this particular area in comparison to other countries. The ISO 9001 and CMM standard has become a basic part of software development. The main objectives of our study are: 1) To understand the software development process uses by the software developer firms in Bangladesh 2) To identify the development practices based on established quality standard and 3) To establish a standardized and coherent process for the development of software for a specific project. It is revealed from this research that software industries of Bangladesh are lacking in target set for software process and improvement, involvement of quality control activities, and standardize business expertise practice. This paper investigates the Bangladeshi software industry in the light of the above challenges.Comment: 13 pages, 3 figures, 11 table

Do Missing Link Community Smell Affect Developers Productivity: An Empirical Study

Missing link smell occurs when developers contribute to the same source code without communicating with each other. Existing studies have analyzed the relationship of missing link smells with code smell and developer contribution. However, the productivity of developers involved in missing link smell has not been explored yet. This study investigates how productivity differs between smelly and non-smelly developers. For this purpose, the productivity of smelly and non-smelly developers of seven open-source projects are analyzed. The result shows that the developers not involved in missing link smell have more productivity than the developers involved in smells. The observed difference is also found statistically significant

An open dataset of <i>Plasmodium vivax</i> genome variation in 1,895 worldwide samples.

This report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.

This report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination